http___www.backtohealthnaturally.com_cervical-cancer-vaccine.xml
http___g.zarez.info_2017_01_24_10-istina-o-raku-vrata-maternice__1.xml
1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 2.1 2.2 2.3 2.4 2.5 2.6 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 4.10 4.11 5.1 6.1 7.1 8.1 9.1 10.1 11.1 12.1 13.1 14.1 15.1 15.2
Cervical cancer is a malignant cancer of the cervix. Cervical cancer is cancer that starts in the cervix, the lower part of the uterus (womb) that opens at the top. The upper part, or body, of the uterus, is where a fetus grows. The cervix connects the body of the uterus to the (birth canal). The part of the cervix closest to the body of the uterus is called the endocervix.. Cancer of the cervix (also known as cervical cancer) begins in the lining of the cervix. Cervical cancers do not form suddenly. Normal cervical cells gradually develop pre-cancerous changes that turn into cancer. Cervical cancer is caused by several types of a virus called human papillomaviruses (HPV). The virus spreads through contact. Most women’s bodies are able to fight HPV infection. Cervical cancer occurs when abnormal cells on the cervix grow out of control. The cervix is the lower part of the uterus that opens. Cervical cancer can often be cured when it’s found early. Cervical cancer is a carcinoma, typically composed of squamous cells, and is similar in some respects to squamous cell cancers of the head and neck and anus. All three of these diseases may be associated with human papillomavirus infection. The remaining 10% to 20% of cervical cancers are adenocarcinomas. Adenocarcinomas are becoming more common in women born in the last 20 to 30 years. Cervical adenocarcinoma develops from the mucus-producing gland cells of the endocervix. Most (80-90%) invasive cervical cancer develops in flat, scaly surface cells that line the cervix (called squamous cell carcinomas). Approximately 10-15% of cases develop in glandular surface cells (called adenocarcinomas). Symptoms of cervical cancer may include is pain during discharge that is tinged with blood and bleeding from that is not normal, or a change in your menstrual cycle. Cervical cancer is staged by the International Federation of Gynecology and Obstetrics (FIGO) staging system, which is based on clinical examination, rather than surgical findings. Cervical cancer is found only in women. Cervical cancers usually affect women of middle age or older, but it may be diagnosed in any reproductive-aged woman. Cervical cancer that is caught early can usually be cured. Microinvasive cancer (stage IA) is usually treated by hysterectomy (removal of the whole uterus). Vaccines have been developed that can protect women from HPV infections. A vaccine that offers protection from the virus responsible for most cases of cervical cancer is the latest addition to the official childhood immunization schedule. The cervical cancer vaccine currently available in Australia is called Gardasil. This vaccine prevents infection with HPV types 16, 18, 6 and 11. HPV 16 and 18 are responsible for the majority (70% internationally; 80% in Australia) of cervical cancers. Cervical cancer strikes more than 10,000 U.S. women each year, killing more than 3,700. The vaccine appears to be virtually 100 percent effective against two of the most common cancer-causing HPV strains. A vaccine for girls and young women protects against the four types of HPV that cause most cervical cancers. Practicing safe (using condoms) also reduces your risk of HPV. Cervical Cancer Treatment Tips Surgery treats the cancer in the cervix and the area close to the tumor. Radiation therapy (also called radiotherapy) uses high-energy rays to kill cancer cells. Chemotherapy uses anticancer drugs to kill cancer cells. Anticancer drugs for cervical cancer are usually given through a vein. Electrosurgery, cryosurgery, podophyllum, and trichloroacetic acid are methods used to remove HPV in mucosal tissue. A vaccine that offers protection from the virus responsible for most cases of cervical cancer Practicing safe (using condoms) also reduces your risk of HPV and STD diseases Avoid Cigarette smoking is associated with an increased risk of cervical cancer. About the Author Juliet Cohen writes articles on diseases and conditions and women health care. More information on health related topics visit our site at http://www.health-care-articles.info.
1.1 1.2 1.3 2.1 3.1 3.2 4.1 5.1 6.1 7.1 8.1 9.1 9.2 10.1 11.1 12.1 13.1 13.2 14.1 14.2 15.1 16.1 17.1 17.2 18.1 19.1 19.2 19.3 19.4 20.1 20.2 21.1 22.1 22.2 23.1 24.1 24.2 24.3 25.1
Rak vrata maternice drugi je naj─Źe┼í─çi rak kod ┼żena i u kriti─Źnoj su skupini ┼żene od 25 do 64 godine. No, ta se kancerogena bolest mo┼że sprije─Źiti i otkriti na vrijeme. Zato je od presudne va┼żnosti da ne zaboravljate i ne preska─Źete redovite kontrole i Papa test. Rak vrata maternice drugi je naj─Źe┼í─çi rak u ┼żena Gledano u svjetskim razmjerima, rak vrata maternice drugi je naj─Źe┼í─çi rak u ┼żena te tre─çi uzrok smrtnosti od raka u ┼żena. Godi┼ínje se u svijetu dijagnosticira oko 500.000 novih slu─Źajeva raka vrata maternice, a gotovo 300 000 ┼żena umre od te bolesti. U Hrvatskoj svaki 3. dan umre jedna ┼żena od raka vrata maternice Procjenjuje se da u Europi svakih 18 minuta, a u svijetu svake dvije minute od raka vrata maternice umre jedna ┼żena. Humani papilomavirus (HPV) je glavni uzro─Źnik raka vrata maternice Niti jedna vrsta raka nema tako ─Źvrstu uzro─Źno posljedi─Źnu vezu s nekim danas znanim uzrokom kao ┼íto to imaju HPV i rak vrata maternice, pa se u ─Źak 99,7 posto slu─Źajeva karcinoma mo┼że dokazati infekcija HPV-om. HPV se prenosi spolnim kontaktom HPV infekcija je vrlo ─Źesta me─Ĺu spolno aktivnim osobama, uglavnom se prenosi tijekom spolnog odnosa i mo┼że se prenijeti izravnim dodirom s osobe na osobu, a ne samo tijekom sno┼íaja. Infekcija HPV-om naj─Źe┼í─ça je u adolescenata, a rak vrata maternice u ┼żena izme─Ĺu 35 i 55 godina. Svaka druga seksualno aktivna osoba je zara┼żena s HPV-om Oko 630 milijuna ljudi diljem svijeta inficirano je s HPV-om, a prema rezultatima nekih ispitivanja u Hrvatskoj s HPV-om je zara┼żeno oko 60 posto spolno aktivnih ┼żena i mu┼íkaraca. Smrtnost od raka vrata maternice je 35 posto U Hrvatskoj svake godine od raka vrata maternice oboli 400, a umre gotovo 140 ┼żena. Ve─çina ┼żena koje obole od raka vrata maternice vjerojatno nikad nisu napravile Papa test ili ga barem nisu napravile u zadnjih 5 godina. Od 1 200 000 ┼żena u Hrvatskoj koje spadaju u najrizi─Źniju skupinu za obolijevanje od raka vrata maternice (od 25 do 64 godine), samo njih 418.000 godi┼ínje napravi PAPA test. To zna─Źi da 2/3 ┼żena ne provodi redovite kontrole, a dodatni problem je ┼íto se uvijek testiraju iste ┼żene. Rak vrata maternice mo┼że se otkriti na vrijeme Papa test je jednostavan test kojim se mo┼że otkriti rak vrata maternice i abnormalne stanice u vratu maternice, ali on ne upu─çuje na glavni uzrok pojave raka i abnormalnih stanica ┼íto je posljedica trajno prisutne infekcije “visoko rizi─Źnim” tipovima HPV-a. Drugi nedostatak Papa testa je 20 – 40 posto la┼żno negativnih nalaza. Zato se kao dodatna pretraga za otkrivanje HPV infekcije koristi teku─ça citologija jer je tada stopa la┼żno negativnih nalaza manja od 5 posto. Rak vrata maternice je najozbiljnija komplikacija HPV infekcije Budu─çi da HPV infekcija obi─Źno nema znakova ili simptoma, ve─çina zara┼żenih osoba toga nije ni svjesna. Ve─çina infekcija HPV-om otkrije se tek s abnormalnim nalazima Papa testa. Niskorizi─Źni tipovi HPV-a mogu dovesti do nastanka spolnih bradavica: nekanceroznih izraslina boje mesa koje se pojave na spolovilu i oko njega. Tipovi HPV-a 6 i 11 odgovorni su za 90 posto svih slu─Źajeva spolnih bradavica. Dugotrajna infekcija visokorizi─Źnim tipovima HPV-a, poput tipova 16,18,31 i 45, mo┼że dovesti do raka vrata maternice i drugih vrsta raka u podru─Źju spolovila. HPV tipovi 16 i 18 su zajedno odgovorni za 70 posto slu─Źajeva raka vrata maternice. Rak vrata maternice mo┼że se sprije─Źiti Iako su kondomi u─Źinkovita sredstva za┼ítite protiv ve─çine spolno prenosivih infekcija, ona ne nude potpunu za┼ítitu u slu─Źaju HPV-a, zato ┼íto HPV mo┼że biti prisutan i na predjelima ko┼że koji nisu za┼íti─çeni. Danas je dostupno cijepivo koje mo┼że za┼ítiti ┼żene od infekcije HPV-om i nastanka raka vrata maternice. Cijepljenjem se spre─Źava rak vrata maternice Prvo cjepivo protiv HPV-a i raka vrata maternice, koje se koristi u SAD-u i EU, dostupno je i na hrvatskom tr┼żi┼ítu. Cjepivo ┼ítiti od infekcije s ─Źetiri tipa virusa HPV-a; tipova 16 i 18 koji su uzrokom 70 posto karcinoma vrata maternice, te tipova 6 i 11 koji uzrokuju oko 90 posto spolnih bradavica. Cjepivo je 100 posto u─Źinkovito u spre─Źavanju HP. Izvor: www.zadovoljna.dnevnik.hr, 21.1.2017.